- Home
- NECB vs TRDA Comparison
NECB vs TRDA Comparison
Compare NECB & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NECB
- TRDA
- Stock Information
- Founded
- NECB 1934
- TRDA 2016
- Country
- NECB United States
- TRDA United States
- Employees
- NECB N/A
- TRDA N/A
- Industry
- NECB Savings Institutions
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- NECB Finance
- TRDA Health Care
- Exchange
- NECB Nasdaq
- TRDA Nasdaq
- Market Cap
- NECB 282.4M
- TRDA 235.4M
- IPO Year
- NECB N/A
- TRDA 2021
- Fundamental
- Price
- NECB $20.23
- TRDA $6.43
- Analyst Decision
- NECB
- TRDA Strong Buy
- Analyst Count
- NECB 0
- TRDA 3
- Target Price
- NECB N/A
- TRDA $25.67
- AVG Volume (30 Days)
- NECB 49.2K
- TRDA 177.0K
- Earning Date
- NECB 10-23-2025
- TRDA 11-06-2025
- Dividend Yield
- NECB 3.96%
- TRDA N/A
- EPS Growth
- NECB N/A
- TRDA N/A
- EPS
- NECB 3.29
- TRDA N/A
- Revenue
- NECB $103,145,000.00
- TRDA $79,476,000.00
- Revenue This Year
- NECB $1.90
- TRDA N/A
- Revenue Next Year
- NECB $6.93
- TRDA N/A
- P/E Ratio
- NECB $6.14
- TRDA N/A
- Revenue Growth
- NECB N/A
- TRDA N/A
- 52 Week Low
- NECB $19.41
- TRDA $4.93
- 52 Week High
- NECB $31.72
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- NECB 46.96
- TRDA 58.36
- Support Level
- NECB $20.00
- TRDA $5.70
- Resistance Level
- NECB $20.63
- TRDA $6.49
- Average True Range (ATR)
- NECB 0.59
- TRDA 0.43
- MACD
- NECB 0.05
- TRDA 0.03
- Stochastic Oscillator
- NECB 48.15
- TRDA 64.93
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.